XML 26 R16.htm IDEA: XBRL DOCUMENT
v3.4.0.3

Warrant Liability (Restated) | 9 Months Ended
--- | ---
Sep. 30, 2015
Warrant Liability [Abstract] |
Warrant Liability [Text Block] | Note 11. Warrant Liability (Restated) Prior to the Merger on December 20, 2013 the Company issued an aggregate of 9,200,000 warrants to purchase its ordinary shares as follows: 4,200,000 warrants issued in connection with Andina’s Initial Public Offering, 4,800,000 warrants issued in connection with a Private Placement simultaneous with the Initial Public Offering and 200,000 working capital warrants issued upon conversion of a promissory note at the closing of the Merger. Following the Notice of Effectiveness of its Registration Statement on June 16, 2014, an aggregate of 1,382,217 warrants have been exercised by investors resulting in 7,817,783 warrants remaining outstanding as of September 30, 2015. The fair value of the warrant liability was determined by the Company using the Binomial Lattice pricing model. This model is dependent upon several variables such as the instrument’s expected term, expected strike price, expected risk-free interest rate over the expected instrument term, the expected dividend yield rate over the expected instrument term and the expected volatility of the Company’s stock price over the expected term. The expected term represents the period of time that the instruments granted are expected to be outstanding. The expected strike price is based upon a weighted average probability analysis of the strike price changes expected during the term because of the down round protection. The risk-free rates are based on U.S. Treasury securities with similar maturities as the expected terms of the options at the date of valuation. Expected dividend yield is based on historical trends. The Company measures volatility using a blended weighted average of the volatility rates for a number of similar publicly traded companies. The inputs to the model were as follows:
|  | September 30, 2015 |  |  | December 31, 2014 |
Stock Price |  | $ | 13.72 |  |  | $ | 10.15 |
Dividend Yield (per quarter per share) |  | $ | 0.125 |  |  |  | N/A |
Risk-free rate |  |  | 0.33 | % |  |  | 0.67 | %
Expected Term (years) |  |  | 1.22 |  |  |  | 1.97 |
Expected Volatility |  |  | 35.00 | % |  |  | 33.62 | %
The table below provides a reconciliation of the beginning and ending balances for the warrant liability measured using significant unobservable inputs (Level 3):
Balance - December 31, 2014 |  | $ | 19,991 |
Fair value adjustment - six months ended June 30, 2015 |  |  | 11,313 |
Balance - June 30, 2015 |  |  | 31,304 |
Fair value adjustment - three months ended September 30, 2015 |  |  | 3,146 |
Balance - September 30, 2015 |  | $ | 34,450 |
The Company’s equity warrants are exercisable by the warrant holder in either of two modes: (i) by making a cash payment at the exercise price and receiving ordinary shares (“cash exercise”), or (ii) by applying a formula in the warrant agreement that is based on the market price of the shares on the NASDAQ market in order to receive ordinary shares for the warrant with no cash payment (“cashless exercise”). Of 1,382,217 aggregate warrants exercised since the merger in December 2013, warrant holders exercised 102,570 warrants on a cash basis and 1,279,647 warrants (14.1% of all warrants outstanding at June 30, 2015) for 532,078 ordinary shares on a cashless basis. When the warrants are exercised for ordinary shares, the Company re-measures the fair value of the exercised warrants as of the date of exercise using quoted prices on the OTC Pink Markets and records the change in fair value in the consolidated statement of operations, and records the fair value of the exercised warrants as additional paid-in capital in the shareholders equity section of the Company’s balance sheet. The Company recorded $ 2,600 and $4,212 respectively in the three- and nine-month periods ended September 30, 2015, in the consolidated statement of operations for the change in fair value of exercised warrants and recorded $7,003 as additional paid-in capital in the shareholders equity of the Company’s condensed consolidated balance sheet for the same periods.
|  | Number of Warrants |  | Average Value |  | Fair Value |
Opening balance as of January 1, 2015 |  |  | 9,097,430 |  | $ | 2.20 |  | $ | 19,991 |
Balance as of June 30, 2015 |  |  | 9,097,430 |  | $ | 3.44 |  | $ | 31,304 |
Change in fair value to the date of cashless exercise charged to income statement |  |  | 1,279,647 |  | $ | 2.03 |  | $ | 2,600 |
Fair value of exercised warrants credited to shareholders equity |  |  | 1,279,647 |  | $ | 5.47 |  | $ | (7,003) |
Change in fair value of unexercised warrants remaining at September 30, 2015 |  |  | 7,817,783 |  | $ | 0.97 |  | $ | 7,548 |
Closing balance as of September 30, 2015 |  |  | 7,817,783 |  | $ | 4.41 |  | $ | 34,450 |
Total change in warrant liability due exercise of warrants and change in fair value of remaining warrants for the three-month period ended September 30, 2015 |  |  |  |  |  |  |  | $ | 3,145 |

X
- References No definition available. + Details
Name: | tgls_WarrantLiabilityAbstract
Namespace Prefix: | tgls_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for warrant liability. + References No definition available. + Details
Name: | tgls_WarrantLiabilityTextBlock
Namespace Prefix: | tgls_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration